Literature DB >> 3096187

Vaccination against Listeria infection in mice with a mutant strain of reduced virulence.

R Fensterbank.   

Abstract

Killed Listeria monocytogenes (L.m.) or living Listeria innocua, being unable to afford noticeable immunity against L.m. challenge in mice, the efficacy of a living strain of L.m. of reduced virulence was studied. This strain was obtained from a field strain of low virulence by successive mutations for streptomycin dependence, reversion to independence and resistance to erythromycin. Its protective immunity was checked in mice against IV, SC and intra-gastric challenges. Vaccinated mice were protected against a IV challenge, lethal for controls, and they were rid of infection in a much shorter time than controls after SC or intra-gastric challenges. They were also protected against abortion when the challenge was done by SC, but not by IV route. The level of immunity was shown to be dose-dependent. Appearing very early after vaccination, immunity remained stable for at least four months, then decreased slowly afterwards, but could be restored and even enhanced by a recall. The protection was equally effective against L.m. serovars 1 or 4 challenges.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3096187

Source DB:  PubMed          Journal:  Ann Rech Vet        ISSN: 0003-4193


  3 in total

1.  Perinatal Listeria monocytogenes susceptibility despite preconceptual priming and maintenance of pathogen-specific CD8(+) T cells during pregnancy.

Authors:  Dayna R Clark; Vandana Chaturvedi; Jeremy M Kinder; Tony T Jiang; Lijun Xin; James M Ertelt; Sing Sing Way
Journal:  Cell Mol Immunol       Date:  2014-09-22       Impact factor: 11.530

2.  Public health impact of foodborne exposure to naturally occurring virulence-attenuated Listeria monocytogenes: inference from mouse and mathematical models.

Authors:  Alison Stout; Anna Van Stelten-Carlson; Hélène Marquis; Michael Ballou; Brian Reilly; Guy H Loneragan; Kendra Nightingale; Renata Ivanek
Journal:  Interface Focus       Date:  2019-12-13       Impact factor: 3.906

3.  Development of Salmonella Enteritidis vaccine candidate based on streptomycin independent suppressor and metabolic drift rifampicin resistance-attenuating markers.

Authors:  Awad A Shehata; Reda Tarabees; Mohamed Elsayed; Gamal Wareth; Shereen Basiouni
Journal:  Heliyon       Date:  2020-08-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.